Published in Proc Natl Acad Sci U S A on October 04, 2010
Female mouse fetal loss mediated by maternal autoantibody. J Exp Med (2012) 1.92
Neural reflexes in inflammation and immunity. J Exp Med (2012) 1.87
Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity. Proc Natl Acad Sci U S A (2011) 1.66
Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med (2012) 1.63
Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna) (2013) 1.20
Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med (2015) 1.00
Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus. J Intern Med (2011) 0.98
Systemic lupus erythematosus, the brain, and anti-NR2 antibodies. J Neurol (2011) 0.97
Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci (2015) 0.96
Brain-reactive antibodies and disease. Annu Rev Immunol (2013) 0.94
Presence of GAD65 autoantibodies in the serum of children with autism or ADHD. Eur Child Adolesc Psychiatry (2012) 0.92
Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease duration. Mol Med (2011) 0.90
B Cell in Autoimmune Diseases. Scientifica (Cairo) (2012) 0.90
Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther (2014) 0.89
Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent. Auto Immun Highlights (2012) 0.86
A model for lupus brain disease. Immunol Rev (2012) 0.85
Microglia of prefrontal white matter in suicide. J Neuropathol Exp Neurol (2014) 0.85
Lessons from an anti-DNA autoantibody. Mol Immunol (2011) 0.85
Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus. Dis Model Mech (2014) 0.84
Anti-NR2A/B Antibodies and Other Major Molecular Mechanisms in the Pathogenesis of Cognitive Dysfunction in Systemic Lupus Erythematosus. Int J Mol Sci (2015) 0.83
Mapping the immunological homunculus. Proc Natl Acad Sci U S A (2011) 0.83
Possible novel biomarkers of organ involvement in systemic lupus erythematosus. Clin Rheumatol (2014) 0.83
Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-d-Aspartate Receptor. EBioMedicine (2015) 0.83
Detection of autoantibodies in a point-of-care rheumatology setting. Auto Immun Highlights (2013) 0.82
16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus. BMC Med (2013) 0.82
Integrative neuroscience approach to neuropsychiatric lupus. Immunol Res (2015) 0.80
Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial. Semin Arthritis Rheum (2011) 0.79
Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy. BMC Med (2013) 0.79
Regional brain metabolism in a murine systemic lupus erythematosus model. J Cereb Blood Flow Metab (2014) 0.78
Antibodies as Mediators of Brain Pathology. Trends Immunol (2015) 0.77
Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus. J Neuroinflammation (2014) 0.77
Effects of prolonged treatment with memantine in the MRL model of CNS lupus. Clin Exp Neuroimmunol (2012) 0.77
Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus. Lupus Sci Med (2015) 0.76
Neuropsychiatric disorders: Neurons excited to death by SLE autoantibodies. Nat Rev Rheumatol (2011) 0.76
C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology (2015) 0.76
A ssDNA Aptamer That Blocks the Function of the Anti-FLAG M2 Antibody. J Nucleic Acids (2011) 0.76
Non-pathogenic tissue-resident CD8(+) T cells uniquely accumulate in the brains of lupus-prone mice. Sci Rep (2017) 0.75
The role of B cells and autoantibodies in neuropsychiatric lupus. Autoimmun Rev (2016) 0.75
Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med (2017) 0.75
Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia. Transl Psychiatry (2017) 0.75
The Role of Brain-Reactive Autoantibodies in Brain Pathology and Cognitive Impairment. Front Immunol (2017) 0.75
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
Role of distinct NMDA receptor subtypes at central synapses. Sci STKE (2004) 4.99
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med (2001) 4.35
Cognition and immunity; antibody impairs memory. Immunity (2004) 3.40
Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A (2006) 2.97
Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J (1999) 2.96
The Yin and Yang of NMDA receptor signalling. Trends Neurosci (2003) 2.83
Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology (2002) 2.68
Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature (2009) 2.64
Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2006) 2.57
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A (2006) 2.51
Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci (1996) 1.99
Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol (2005) 1.96
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum (2006) 1.87
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc Natl Acad Sci U S A (2006) 1.74
Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J Neurochem (2002) 1.70
Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med (2008) 1.54
Losing your nerves? Maybe it's the antibodies. Nat Rev Immunol (2009) 1.52
Kinetic basis of partial agonism at NMDA receptors. Nat Neurosci (2009) 1.45
Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One (2008) 1.45
Mechanisms underlying the loss of mitochondrial membrane potential in glutamate excitotoxicity. Biochim Biophys Acta (2008) 1.42
In developing hippocampal neurons, NR2B-containing N-methyl-D-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death. Neuroscience (2008) 1.36
Excitotoxic calcium overload in a subpopulation of mitochondria triggers delayed death in hippocampal neurons. J Neurosci (2004) 1.30
Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2008) 1.28
Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis (2005) 1.24
Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol (2006) 1.22
Neuropsychiatric lupus. Rheum Dis Clin North Am (2005) 1.20
Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives. Lupus (2007) 1.09
Calcium-dependent spontaneously reversible remodeling of brain mitochondria. J Biol Chem (2006) 1.07
Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med (2006) 1.03
Cognitive dysfunction in systemic lupus erythematosus: past, present, and future. Arthritis Rheum (2008) 1.01
Identification of DNA-reactive B cells in patients with systemic lupus erythematosus. J Immunol Methods (2008) 1.00
Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition. Neurobiol Aging (2007) 0.93
Mitochondrial permeability transition can be directly monitored in living neurons. Biomed Pharmacother (2002) 0.87
Special report: adjusted lupus prevalence. Results of a marketing study by the Lupus Foundation of America. Lupus (1995) 0.81
Antibodies to bovine serum albumin do not affect the results of enzyme-linked immunosorbent assays for IgG anti-NR2 glutamate receptor antibodies: reply to the letter by Hirohata et al. Arthritis Rheum (2007) 0.81
A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A (2004) 44.81
Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med (2007) 9.83
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A (2003) 8.21
Robot-assisted therapy for long-term upper-limb impairment after stroke. N Engl J Med (2010) 6.21
Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell (2009) 5.74
Analyses of pig genomes provide insight into porcine demography and evolution. Nature (2012) 5.58
Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med (2005) 5.50
Lanthanide-transition-metal sandwich framework comprising {Cu3} cluster pillars and layered networks of {Er36} wheels. Angew Chem Int Ed Engl (2005) 4.93
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum (2012) 4.80
Unsupervised learning of an atlas from unlabeled point-sets. IEEE Trans Pattern Anal Mach Intell (2004) 4.63
Cross-leg flaps: our preferred alternative to free flaps in the treatment of complex traumatic lower extremity wounds. J Am Coll Surg (2013) 4.30
ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell (2011) 4.26
Opposing LSD1 complexes function in developmental gene activation and repression programmes. Nature (2007) 4.12
Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study. Arthritis Rheum (2013) 4.02
A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum (2012) 4.01
Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med (2009) 3.97
Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature (2013) 3.93
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum (2011) 3.81
Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature (2003) 3.72
Recognizing names in biomedical texts: a machine learning approach. Bioinformatics (2004) 3.70
Expression analysis of G Protein-Coupled Receptors in mouse macrophages. Immunome Res (2008) 3.54
Genomic analyses identify distinct patterns of selection in domesticated pigs and Tibetan wild boars. Nat Genet (2013) 3.41
Cognition and immunity; antibody impairs memory. Immunity (2004) 3.40
The phosphothreonine lyase activity of a bacterial type III effector family. Science (2007) 3.18
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol (2003) 3.10
Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci U S A (2007) 3.06
The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2006) 3.05
Dorsal root ganglion neurons innervating skeletal muscle respond to physiological combinations of protons, ATP, and lactate mediated by ASIC, P2X, and TRPV1. J Neurophysiol (2008) 2.99
Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry. J Clin Oncol (2012) 2.98
Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A (2006) 2.97
Pseudomonas syringae effector AvrPto blocks innate immunity by targeting receptor kinases. Curr Biol (2007) 2.84
Porous lanthanide-organic open frameworks with helical tubes constructed from interweaving triple-helical and double-helical chains. Angew Chem Int Ed Engl (2005) 2.83
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg (2008) 2.79
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A (2006) 2.51
Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum (2009) 2.50
Recognition of protein/gene names from text using an ensemble of classifiers. BMC Bioinformatics (2005) 2.42
Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell (2006) 2.40
On the track of neuropsychiatric lupus. Arthritis Rheum (2003) 2.39
Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant (2004) 2.35
Gene set enrichment in eQTL data identifies novel annotations and pathway regulators. PLoS Genet (2008) 2.32
Rehabilitation robotics: pilot trial of a spatial extension for MIT-Manus. J Neuroeng Rehabil (2004) 2.31
Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma. Cancer (2012) 2.24
Meta-analysis added power to identify variants in FTO associated with type 2 diabetes and obesity in the Asian population. Obesity (Silver Spring) (2010) 2.15
Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res (2004) 2.11
Subcellular heterogeneity of sodium current properties in adult cardiac ventricular myocytes. Heart Rhythm (2011) 2.10
Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels. J Biol Chem (2004) 2.08
Diverse CD81 proteins support hepatitis C virus infection. J Virol (2006) 2.07
Superfamily phenomena and motifs of networks induced from time series. Proc Natl Acad Sci U S A (2008) 2.06
Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol (2007) 2.05
The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther (2007) 2.05
Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest (2006) 2.05
Effect of thimerosal on the neurodevelopment of premature rats. World J Pediatr (2013) 2.04
A series of luminescent lanthanide-cadmium-organic frameworks with helical channels and tubes. Chem Commun (Camb) (2006) 2.01
Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science (2004) 2.00
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum (2008) 2.00
Jamming by shear. Nature (2011) 1.98
Age-related differences in unruptured intracranial aneurysms: 1-year outcomes. J Neurosurg (2014) 1.96
Flagellin induces innate immunity in nonhost interactions that is suppressed by Pseudomonas syringae effectors. Proc Natl Acad Sci U S A (2005) 1.94
A germanate framework containing 24-ring channels, Ni--Ge bonds, and chiral [Ni@Ge14O24(OH)3] cluster motifs transferred from chiral metal complexes. Angew Chem Int Ed Engl (2005) 1.94
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor. Cancer Res (2005) 1.94
Female mouse fetal loss mediated by maternal autoantibody. J Exp Med (2012) 1.92
Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. Arthritis Care Res (Hoboken) (2013) 1.92
Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet (2012) 1.91
Complete genome sequence of a highly prevalent isolate of porcine epidemic diarrhea virus in South China. J Virol (2012) 1.91
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum (2006) 1.87
Changes in HIV prevalence and sexual behavior among men who have sex with men in a northern Chinese city: 2002-2006. J Infect (2007) 1.86
Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther (2002) 1.82
Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function. Eur J Pharmacol (2009) 1.81
Practical guidelines for the comprehensive analysis of ChIP-seq data. PLoS Comput Biol (2013) 1.81
Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med (2006) 1.81
A 3D coordination framework based on linkages of nanosized hydroxo lanthanide clusters and copper centers by isonicotinate ligands. Angew Chem Int Ed Engl (2005) 1.78
Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest (2002) 1.76
Immunity and acquired alterations in cognition and emotion: lessons from SLE. Adv Immunol (2006) 1.74
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc Natl Acad Sci U S A (2006) 1.74
Complete genome sequence of a novel porcine epidemic diarrhea virus in south China. J Virol (2012) 1.73
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myeloma. Clin Cancer Res (2012) 1.73
XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development. J Exp Med (2009) 1.71
A model for harmonizing flow cytometry in clinical trials. Nat Immunol (2010) 1.70
Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet (2002) 1.69
Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity. Proc Natl Acad Sci U S A (2011) 1.66
Disruption of PAMP-induced MAP kinase cascade by a Pseudomonas syringae effector activates plant immunity mediated by the NB-LRR protein SUMM2. Cell Host Microbe (2012) 1.66
TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Mol Cell (2008) 1.65
DelPhi: a comprehensive suite for DelPhi software and associated resources. BMC Biophys (2012) 1.64
Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population. Atherosclerosis (2011) 1.64
Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler Thromb Vasc Biol (2008) 1.64
Role of the Arabidopsis thaliana NAC transcription factors ANAC019 and ANAC055 in regulating jasmonic acid-signaled defense responses. Cell Res (2008) 1.63